162 related articles for article (PubMed ID: 3706414)
1. Zellweger syndrome: diagnostic assays, syndrome delineation, and potential therapy.
Wilson GN; Holmes RG; Custer J; Lipkowitz JL; Stover J; Datta N; Hajra A
Am J Med Genet; 1986 May; 24(1):69-82. PubMed ID: 3706414
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of enzymes catalyzing the biosynthesis of glycerol-ether lipids in Zellweger syndrome. A new category of metabolic disease involving the absence of peroxisomes.
Datta NS; Wilson GN; Hajra AK
N Engl J Med; 1984 Oct; 311(17):1080-3. PubMed ID: 6566965
[TBL] [Abstract][Full Text] [Related]
3. Neonatal adrenoleukodystrophy: new cases, biochemical studies, and differentiation from Zellweger and related peroxisomal polydystrophy syndromes.
Kelley RI; Datta NS; Dobyns WB; Hajra AK; Moser AB; Noetzel MJ; Zackai EH; Moser HW
Am J Med Genet; 1986 Apr; 23(4):869-901. PubMed ID: 3515938
[TBL] [Abstract][Full Text] [Related]
4. Aberration in de novo ether lipid biosynthesis in peroxisomal disorders.
van den Bosch H; Schalkwijk CG; Schrakamp G; Wanders RJ; Schutgens RB; Schram AW; Tager JM
Prog Clin Biol Res; 1988; 282():139-50. PubMed ID: 3071794
[TBL] [Abstract][Full Text] [Related]
5. Peroxisomal disorders: clinical commentary and future prospects.
Wilson GN; Holmes RD; Hajra AK
Am J Med Genet; 1988 Jul; 30(3):771-92. PubMed ID: 2461077
[TBL] [Abstract][Full Text] [Related]
6. Neonatal adrenoleukodystrophy. Impaired plasmalogen biosynthesis and peroxisomal beta-oxidation due to a deficiency of catalase-containing particles (peroxisomes) in cultured skin fibroblasts.
Wanders RJ; Schutgens RB; Schrakamp G; Tager JM; Van den Bosch H; Moser AB; Moser HW
J Neurol Sci; 1987 Feb; 77(2-3):331-40. PubMed ID: 3819771
[TBL] [Abstract][Full Text] [Related]
7. Zellweger syndrome: first reported case in Thailand and literature review.
Jaruratanasirikul S; Vasiknanont P; Saetung P; Mitarnun W
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():47-51. PubMed ID: 8629140
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis of Zellweger's cerebrohepatorenal syndrome].
Schutgens RB; Heymans HS; Purvis R; Wanders RJ; Schrakamp G; van den Bosch H
Tijdschr Kindergeneeskd; 1984 Dec; 52(6):231-8. PubMed ID: 6528320
[TBL] [Abstract][Full Text] [Related]
9. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel PEX14 mutation in Zellweger syndrome.
Huybrechts SJ; Van Veldhoven PP; Hoffman I; Zeevaert R; de Vos R; Demaerel P; Brams M; Jaeken J; Fransen M; Cassiman D
J Med Genet; 2008 Jun; 45(6):376-83. PubMed ID: 18285423
[TBL] [Abstract][Full Text] [Related]
11. The role of peroxisomes in glycerol ether lipid metabolism.
Hajra AK; Horie S; Webber KO
Prog Clin Biol Res; 1988; 282():99-116. PubMed ID: 3071810
[TBL] [Abstract][Full Text] [Related]
12. Plasmalogen biosynthesis in the diagnosis of peroxisomal disorders.
Kremser K; Roscher A
J Clin Chem Clin Biochem; 1989 May; 27(5):315-7. PubMed ID: 2760566
[TBL] [Abstract][Full Text] [Related]
13. Multiple peroxisomal enzymatic deficiency disorders. A comparative biochemical and morphologic study of Zellweger cerebrohepatorenal syndrome and neonatal adrenoleukodystrophy.
Vamecq J; Draye JP; Van Hoof F; Misson JP; Evrard P; Verellen G; Eyssen HJ; Van Eldere J; Schutgens RB; Wanders RJ
Am J Pathol; 1986 Dec; 125(3):524-35. PubMed ID: 2879480
[TBL] [Abstract][Full Text] [Related]
14. Zellweger syndrome knockout mouse models challenge putative peroxisomal beta-oxidation involvement in docosahexaenoic acid (22:6n-3) biosynthesis.
Infante JP; Huszagh VA
Mol Genet Metab; 2001 Jan; 72(1):1-7. PubMed ID: 11161822
[TBL] [Abstract][Full Text] [Related]
15. Properties of the enzymes catalyzing the biosynthesis of lysophosphatidate and its ether analog in cultured fibroblasts from Zellweger syndrome patients and normal controls.
Webber KO; Datta NS; Hajra AK
Arch Biochem Biophys; 1987 May; 254(2):611-20. PubMed ID: 3646870
[TBL] [Abstract][Full Text] [Related]
16. Analysis of very long-chain fatty acids and plasmalogen in the erythrocyte membrane: a simple method for the detection of peroxisomal disorders and discrimination between adrenoleukodystrophy and Zellweger syndrome.
Tanaka K; Nishizawa K; Yamamoto H; Naruto T; Izeki E; Taga T; Shimada M; Saeki Y
Neuropediatrics; 1990 Aug; 21(3):119-23. PubMed ID: 2234315
[TBL] [Abstract][Full Text] [Related]
17. [Retinopathy in Zellweger's cerebrohepatorenal syndrome. The electrophysiological aspects].
Stănescu-Segall B
Oftalmologia; 1996; 40(4):357-60. PubMed ID: 8962865
[TBL] [Abstract][Full Text] [Related]
18. [The contribution of peroxisomes to lipid metabolism].
Kramar R
J Clin Chem Clin Biochem; 1986 Feb; 24(2):109-18. PubMed ID: 3711795
[TBL] [Abstract][Full Text] [Related]
19. Deficiency of plasmalogens in the cerebro-hepato-renal (Zellweger) syndrome.
Heymans HS; vd Bosch H; Schutgens RB; Tegelaers WH; Walther JU; Müller-Höcker J; Borst P
Eur J Pediatr; 1984 Apr; 142(1):10-5. PubMed ID: 6714253
[TBL] [Abstract][Full Text] [Related]
20. [Zellweger syndrome. Reports on two new cases].
Cáceres-Marzal C; Vaquerizo-Madrid J; Girós M; Ruiz F; Roels F
Rev Neurol; 2003 Jun 1-15; 36(11):1030-4. PubMed ID: 12808498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
